Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawsuit Filed Over Pradaxa Gastrointestinal Bleeding Death August 14, 2012 Austin Kirk Add Your Comments A wrongful death lawsuit has been filed by a Tennessee man, who alleges that his mother died from gastrointestinal bleeding caused by Pradaxa, adding to the growing number of cases filed by individuals throughout the United States over the relatively new anticoagulant that was introduced by Boehringer Ingelheim in 2010. The complaint (PDF) was filed in the U.S. District Court for the Western District of Tennessee on August 8, by James Lunsford, whose mother, Imojean Lunsford, died in April 2011. According to the lawsuit, Imojean Lunsford was prescribed Pradaxa in December 2010, shortly after it was approved in the United States for prevention of strokes among individuals with atrial fibrillation. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Lunsford was hospitalized for gastrointestinal bleeding on March 29, 2011, which was allegedly caused by Pradaxa. Although the bleeding was diagnosed, doctors were unable to control it. She received dialysis treatment to remove Pradaxa from her blood, but doctors were unable to reverse the effects of Pradaxa, and she died on April 7, 2011. Pradaxa Gastrointestinal Bleeding Was Fatal Due to Lack of Reversal Agent Pradaxa (dabigitran) was introduced by Boehringer Ingelheim as a superior alternative to Coumadin, known generically as warfarin. However, unlike the older anticoagulant, Pradaxa has no reversal agent or antidote to reverse the effects of the drug when severe bleeding events occur. The lawsuit alleges that Boehringer Ingelheim failed to provide sufficient warnings about the risk of bleeding and the lack of a reversal agent. Lunsford and her physicians were unaware and could not have reasonably learned that the use of Pradaxa would expose her to a risk of excessive and uncontrollable bleeding, according to the complaint. James Lunsford indicates that had Boehringer Ingelheim provided adequate warnings that there is no agent to reverse the Pradaxa side effects, Imojean Lunsford never would have used the newer medication instead of warfarin/Coumadin. Similar allegations have been raised in several dozen Pradaxa lawsuits filed by individuals throughout the United States who have suffered gastrointestinal bleeding or wrongful death from Pradaxa. Pradaxa Litigation Consolidated in MDL Lunsford’s case will soon be transferred to the recently established Pradaxa MDL, or multidistrict litigation, where it will be coordinated with all other lawsuits filed in the federal court system. According to an order issued last week by the U.S. Judicial Panel on Multidistrict Litigation, all federal cases will be centralized in the U.S. District Court for the Southern District of Illinois, before Judge David R. Herndon. While there are currently about 50 cases pending in the federal Pradaxa litigation, the number of lawsuit is expected to continue to grow in the coming weeks, as the organization and structure of the MDL is established. Judge Herndon will preside over all pretrial proceedings, as well as any bellwether trials that may be scheduled to assist the parties in gauging how juries are likely to react to certain evidence and testimony that may be offered in multiple cases. However, if an agreement to settle the Pradaxa cases is not be reached during the MDL proceedings, the cases may be remanded back to the U.S. District Courts where they were originally filed for individual trials. Tags: Blood Thinner, Blood Thinners, Boehringer Ingelheim, Coumadin, Pradaxa, Warfarin, Wrongful Death More Pradaxa Lawsuit Stories Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim May 21, 2019 Paragard IUD Lawsuit Dismissed on Summary Judgment February 25, 2019 Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025) 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)